PANGYO, South Korea I 10, 2024 I Huonslab, a subsidiary of Huons Global (KOSDAQ: 084110), announced today the successful enrollment and ...

Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US First non-mRNA combination vaccine candidates that include two already licensed ...

Background and aims Pyrrolizidine alkaloids (PAs), widely distributed in plants, are known to induce liver failure. Hepatic ...

The European Medicines Agency (EMA) has validated Chiesi Global Rare Diseases and Protalix BioTherapeutics’ submission to ...

GeoVax Labs (GOVX) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent Application No. 17/876,682 ...

Stable disease (SD) at four months post-initiation of dosing was seen in 10 of 21 (48%) evaluable monotherapy patients, and importantly included one patient dosed at the MTD who had a partial response ...

Interleukin-2 (IL-2) is a well-known cytokine that plays a crucial role in stimulating immune cells, including natural killer (NK) cells and cytotoxic T cells. It has been studied as an immunotherapy ...

Plus: Peter Pan panto, Atsushi Kaga's bunnies, Velveteen Rabbit, 40 years of Lab, DJ Louie Vega, East Bay Zine Fest, more ...

Learn how the new immunization strategy uses adjuvanted DNA plasmids and calcium phosphate nanoparticles to prevent ILT.